Universe Pharmaceuticals Inc Class A
As of Oct 22, 2026, Universe Pharmaceuticals is in Stage 3, the topping phase, now in its first week (since Oct 16, 2026). It closed at $4.38, 64.0% below its 52-week high and above its 200-day average, which is rising.
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is UPC early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
UPC among Drug Manufacturers - Specialty & Generic38th of 84 by relative strength
All 84 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CPIX | Stage 2 · wk 23 | 98 | +6.8% |
| 2 | ETON | Stage 2 · wk 30 | 97 | −10.1% |
| 3 | ANIK | Stage 2 · wk 15 | 96 | +3.5% |
| 4 | IRWD | Stage 3 · wk 3 | 96 | −16.4% |
| 5 | TEVA | Stage 2 · wk 9 | 95 | +3.1% |
| 6 | AMRX | Stage 2 · wk 19 | 95 | +5.9% |
| 7 | KNSA | Stage 2 · wk 73 | 95 | +6.2% |
| 8 | AMLX | Stage 2 · wk 15 | 93 | −6.6% |
| …38 | UPC | Stage 3 · wk 1 | 42 | −6.6% |
Universe Pharmaceuticals: quick answers
What stage is Universe Pharmaceuticals in?
As of Oct 22, 2026, Universe Pharmaceuticals (UPC) is in Stage 3, the topping phase. It entered Stage 3 on Oct 16, 2026 and is in its first week there. What the four stages mean
Is Universe Pharmaceuticals in an uptrend?
Its uptrend has stalled. Universe Pharmaceuticals is in Stage 3, the topping phase that follows an advance. It trades 13.1% above its 200-day average, which is rising.
How far is Universe Pharmaceuticals from its 52-week high?
Universe Pharmaceuticals closed at $4.38 on Oct 22, 2026, 64.0% below its 52-week high of $12.18. Its 52-week low is $2.25.
How has Universe Pharmaceuticals performed over the past year?
As of Oct 22, 2026, Universe Pharmaceuticals is down 16.6% over the past year and up 5.3% so far in 2026.
Which sector and industry is Universe Pharmaceuticals in?
Universe Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.
About this companyHealth Care· Drug Manufacturers - Specialty & Generic
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.